Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein

被引:0
|
作者
Nadvia Delhem
Abdelmajid Sabile
Rodrigo Gajardo
Philippe Podevin
Annie Abadie
Maria Agnes Blaton
Dina Kremsdorf
Laura Beretta
Christian Brechot
机构
[1] Department of Liver Cancer and Molecular Virology Inserm U370 CHU Necker,Department of Microbiology and Immunology
[2] Department of Cytokines and Interferon,Department of Viral Investigation
[3] Curie Institute,undefined
[4] University of Michigan,undefined
[5] Desarollo Institut,undefined
[6] Department of Hepato-gastroenterology Saint-Antoine hospital,undefined
来源
Oncogene | 2001年 / 20卷
关键词
HCV; core; PKR; eIF2α; apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatitis C virus (HCV) is a major etiological agent of chronic liver disease and hepatocellular carcinoma (HCC). We demonstrate herewith that HCV core proteins encoded by sequences isolated from HCC tumor tissues, but not those derived from their non-tumor counterparts in the same liver, co-localise in vitro and in vivo and co-immunoprecipitate with PKR in hepatocytic Huh7 cells. We show that this association in fact augments the autophosphorylation of PKR and the phosphorylation of the translation initiation factor eIF2α, which are two markers of PKR activity. The present study therefore identifies a novel model of virus-cell interactions whereby a viral protein, the HCV core, activates PKR activity.
引用
收藏
页码:5836 / 5845
页数:9
相关论文
共 50 条
  • [1] Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein
    Delhem, N
    Sabile, A
    Gajardo, R
    Podevin, P
    Abadie, A
    Blaton, MA
    Kremsdorf, D
    Beretta, L
    Brechot, C
    [J]. ONCOGENE, 2001, 20 (41) : 5836 - 5845
  • [2] Ebola virus protein VP35 inhibits activation of the interferon-inducible kinase PKR by RNA
    Eitan, Maayan
    Osman, Farhat
    Namer, Lise Sarah
    Eliahu, Einav
    Banai, Yona
    Kaempfer, Raymond
    [J]. CYTOKINE, 2008, 43 (03) : 298 - 298
  • [3] Activation of the interferon-inducible 2′-5′-oligoadenylate synthetase gene by hepatitis C virus core protein
    Naganuma, A
    Nozaki, A
    Tanaka, T
    Sugiyama, K
    Takagi, H
    Mori, M
    Shimotohno, K
    Kato, N
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (18) : 8744 - 8750
  • [4] Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element
    Dansako, H
    Naganuma, A
    Nakamura, T
    Ikeda, F
    Nozaki, A
    Kato, N
    [J]. VIRUS RESEARCH, 2003, 97 (01) : 17 - 30
  • [5] A diminished activation capacity of the interferon-inducible protein kinase PKR in human T lymphocytes
    Li, SY
    Nagai, K
    Koromilas, AE
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (06): : 1598 - 1606
  • [6] The PKR protein kinase - An interferon-inducible regulator of cell growth and differentiation
    Samuel, CE
    Kuhen, KL
    George, CX
    Ortega, LG
    RendeFournier, R
    Tanaka, H
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 65 (03) : 227 - 237
  • [7] Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
    Taylor, DR
    Shi, ST
    Romano, PR
    Barber, GN
    Lai, MMC
    [J]. SCIENCE, 1999, 285 (5424) : 107 - 110
  • [8] Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase
    George, CX
    Thomis, DC
    McCormack, SJ
    Svahn, CM
    Samuel, CE
    [J]. VIROLOGY, 1996, 221 (01) : 180 - 188
  • [9] THE INTERFERON-INDUCIBLE PROTEIN-KINASE PKR MODULATES THE TRANSCRIPTIONAL ACTIVATION OF IMMUNOGLOBULIN-KAPPA GENE
    KOROMILAS, AE
    CANTIN, C
    CRAIG, AWB
    JAGUS, R
    HISCOTT, J
    SONENBERG, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) : 25426 - 25434